Literature DB >> 22008333

Proteomics-based identification of spontaneous regression-associated proteins in neuroblastoma.

Fang Yu1, Xiudan Zhu, Chen Feng, Tianyou Wang, Qin Hong, Zhoulu Liu, Suoqin Tang.   

Abstract

BACKGROUND: Spontaneous regression is usually found in stage 4s neuroblastoma, whereas the elucidation of the underlying molecular mechanism(s) is still limited.
PURPOSE: Our study aims to investigate the pathogenesis of spontaneous regression at the protein level. METHODS AND MATERIALS: Differential expression of proteins in stage 4s neuroblastoma tissue, in stage 4 neuroblastoma tissue, and in normal adrenal tissue was investigated by use of 2-dimensional difference gel electrophoresis (2D-DIGE).
RESULTS: Twenty-four protein spots were found to have significant changes among the different tissues, in which 16 proteins were identified using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS). Among these proteins, 7 proteins (RhoGDP-dissociation inhibitor 1, phosphatidylethanolamine-binding protein, prohibitin, etc) were up-regulated and 2 proteins (F-actin capping protein 1 subunit and aldose reductase) were down-regulated in stage 4s neuroblastoma compared with stage 4 neuroblastoma. The differential expression of selected candidate protein (RhoGDP-dissociation inhibitor 1 and CAPZA1) was further validated by western blotting.
CONCLUSION: Some proteins are differentially expressed between stage 4s and stage 4 neuroblastoma tissue, including those associated with differentiation and proliferation as well as apoptosis. RhoGDP-dissociation inhibitor 1 is highly expressed in stage 4s neuroblastoma tissue, whereas CAPZA1 is down-regulated.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22008333     DOI: 10.1016/j.jpedsurg.2011.06.024

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  10 in total

Review 1.  Spontaneous regression of neuroblastoma.

Authors:  Garrett M Brodeur
Journal:  Cell Tissue Res       Date:  2018-01-05       Impact factor: 5.249

Review 2.  Mechanisms of neuroblastoma regression.

Authors:  Garrett M Brodeur; Rochelle Bagatell
Journal:  Nat Rev Clin Oncol       Date:  2014-10-21       Impact factor: 66.675

3.  Advancing Clinicopathologic Diagnosis of High-risk Neuroblastoma Using Computerized Image Analysis and Proteomic Profiling.

Authors:  M Khalid Khan Niazi; Jonathan H Chung; Katherine J Heaton-Johnson; Daniel Martinez; Raquel Castellanos; Meredith S Irwin; Stephen R Master; Bruce R Pawel; Metin N Gurcan; Daniel A Weiser
Journal:  Pediatr Dev Pathol       Date:  2017-04-18

4.  Collective cell traction force analysis on aligned smooth muscle cell sheet between three-dimensional microwalls.

Authors:  Ying Zhang; Soon Seng Ng; Yilei Wang; Huixing Feng; Wei Ning Chen; Mary B Chan-Park; Chuan Li; Vincent Chan
Journal:  Interface Focus       Date:  2014-04-06       Impact factor: 3.906

5.  A distinct Smoothened mutation causes severe cerebellar developmental defects and medulloblastoma in a novel transgenic mouse model.

Authors:  Joyoti Dey; Sally Ditzler; Sue E Knoblaugh; Beryl A Hatton; Janell M Schelter; Michele A Cleary; Brig Mecham; Lucy B Rorke-Adams; James M Olson
Journal:  Mol Cell Biol       Date:  2012-08-06       Impact factor: 4.272

6.  Application of proteomics to soft tissue sarcomas.

Authors:  Tadashi Kondo; Daisuke Kubota; Akira Kawai
Journal:  Int J Proteomics       Date:  2012-06-19

7.  CAPZA1 modulates EMT by regulating actin cytoskeleton remodelling in hepatocellular carcinoma.

Authors:  Deng Huang; Li Cao; Shuguo Zheng
Journal:  J Exp Clin Cancer Res       Date:  2017-01-16

8.  miR-875-5p exerts tumor-promoting function via down-regulation of CAPZA1 in esophageal squamous cell carcinoma.

Authors:  Nan Kang; Yunwei Ou; Guangchao Wang; Jie Chen; Dan Li; Qimin Zhan
Journal:  PeerJ       Date:  2021-01-05       Impact factor: 2.984

9.  Combined analysis of RNA-sequence and microarray data reveals effective metabolism-based prognostic signature for neuroblastoma.

Authors:  Xinyao Meng; Chenzhao Feng; Erhu Fang; Jiexiong Feng; Xiang Zhao
Journal:  J Cell Mol Med       Date:  2020-07-19       Impact factor: 5.310

10.  Identification of prognostic long noncoding RNAs associated with spontaneous regression of neuroblastoma.

Authors:  Xinyao Meng; Erhu Fang; Xiang Zhao; Jiexiong Feng
Journal:  Cancer Med       Date:  2020-03-26       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.